Clinical trial
The APSANTICO-registry - Evaluation of the Efficacy and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome (APS)
NCT05195372 is registered in ClinicalTrials.gov with Cardioangiologisches Centrum Bethanien as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The APSANTICO-registry - Evaluation of the Efficacy and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome (APS)
- Lead sponsor
- Cardioangiologisches Centrum Bethanien
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- July 31, 2022
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antiphospholipid syndrome, arterial thromboembolism, major bleed, venous thromboembolism